| Literature DB >> 27013913 |
Fereshteh Shiri1, Somayeh Pirhadi2, Jahan B Ghasemi2.
Abstract
Mer receptor tyrosine kinase is a promising novel cancer therapeutic target in many human cancers, because abnormal activation of Mer has been implicated in survival signaling and chemoresistance. 3D-QSAR analyses based on alignment independent descriptors were performed on a series of 81 Mer specific tyrosine kinase inhibitors. The fractional factorial design (FFD) and the enhanced replacement method (ERM) were applied and tested as variable selection algorithms for the selection of optimal subsets of molecular descriptors from a much greater pool of such regression variables. The data set was split into 65 molecules as the training set and 16 compounds as the test set. All descriptors were generated by using the GRid INdependent descriptors (GRIND) approach. After variable selection, GRIND were correlated with activity values (pIC50) by PLS regression. Of the two applied variable selection methods, ERM had a noticeable improvement on the statistical parameters of PLS model, and yielded a q (2) value of 0.77, an [Formula: see text] of 0.94, and a low RMSEP value of 0.25. The GRIND information contents influencing the affinity on Mer specific tyrosine kinase were also confirmed by docking studies. In a quantum calculation study, the energy difference between HOMO and LUMO (gap) implied the high interaction of the most active molecule in the active site of the protein. In addition, the molecular electrostatic potential energy at DFT level confirmed results obtained from the molecular docking. The identified key features obtained from the molecular modeling, enabled us to design novel kinase inhibitors.Entities:
Keywords: Enhanced replacement method; Fractional factorial design; GRIND; Mer receptor tyrosine kinase; Molecular docking
Year: 2015 PMID: 27013913 PMCID: PMC4792907 DOI: 10.1016/j.jsps.2015.03.012
Source DB: PubMed Journal: Saudi Pharm J ISSN: 1319-0164 Impact factor: 4.330
Structures of Mer specific tyrosine kinase inhibitors along with their pIC50 values.
| Compound | pIC50 | ||
|---|---|---|---|
| M01 | 8.2 | ||
| M02 | 8.55 | ||
| M03 | 8.41 | ||
| M04 | 8.77 | ||
| M05 | 7.92 | ||
| M06 | 7.74 | ||
| M07 | 8.96 | ||
| M08 | 8.77 | ||
| M09 | 9.15 | ||
| M10 | 9.16 | ||
| M11 | 8.47 | ||
| M12 | 9.16 | ||
| M13 | 8.89 | ||
| M14 | 9.09 | ||
| Compound | pIC50 | ||
| M15 | 5.9 | ||
| M16 | 8.74 | ||
| M17 | 8.35 | ||
| M18 | 7.74 | ||
| M19 | 7.47 | ||
| M20 | 7.14 | ||
| M21 | 6.8 | ||
| M22 | 6.7 | ||
| M23 | 5.95 | ||
| M24 | 6.22 | ||
| Compound | pIC50 | ||
| M25 | 5.57 | ||
| M26 | 6.27 | ||
| M27 | 6.77 | ||
| M28 | 7.3 | ||
| M29 | 7.72 | ||
| M30 | 7.36 | ||
| M31 | 6.42 | ||
| M32 | 4.78 | ||
| M33 | 7.08 | ||
| M34 | 6.96 | ||
| M35 | 7.85 | ||
| M36 | 6.49 | ||
| M37 | 6.66 | ||
| M38 | 7.36 | ||
| Compound | NHR2 | pIC50 | |
| M39 | 7.4 | ||
| M40 | 4.9 | ||
| M41 | 7.64 | ||
| Compound | pIC50 | ||
| M42 | 7.17 | ||
| M43 | 5.23 | ||
| M44 | 8.05 | ||
| M45 | 5.6 | ||
| M46 | 8.08 | ||
| M47 | 8.39 | ||
| M48 | 7.89 | ||
| M49 | 8.1 | ||
| M50 | 6.64 | ||
| M51 | 7.82 | ||
| M52 | 7.54 | ||
| M53 | 7.41 | ||
| M54 | 7.85 | ||
| M55 | 8.17 | ||
| M56 | 8.2 | ||
| M57 | 7.85 | ||
| M58 | 8.28 | ||
| M59 | 8.37 | ||
| Compound | NHR2 | pIC50 | |
| M60 | 8.68 | ||
| M61 | 6.23 | ||
| M62 | 7.43 | ||
| M63 | 6.85 | ||
| M64 | 7.21 | ||
| M65 | 6 | ||
| M66 | 6.96 | ||
| M67 | 6.21 | ||
| M68 | 6.77 | ||
| M69 | 5 | ||
| Compound | NHR3 | pIC50 | |
| M70 | 5.62 | ||
| M71 | 6.82 | ||
| M72 | 7.43 | ||
| M73 | 7.96 | ||
| M74 | 7.57 | ||
| M75 | 8.14 | ||
| M76 | 7.07 | ||
| M77 | 7.23 | ||
| M78 | 7.62 | ||
| M79 | 7.33 | ||
| M80 | 6.74 | ||
| M81 | 6.92 | ||
Test set.
Figure 1The most active molecule 12 docked into the cavity of Mer kinase.
Figure 2The PLS coefficient histogram of FFD-PLS, showing the importance of single descriptors to explain the Y: positive values of a coefficient indicate a direct correlation to the Y, and negative ones indicate an inverse correlation to the Y.
Figure 3Plot of experimental versus predicted activities for the ERM-PLS model.
Figure 4The domain of applicability of ERM-PLS on the GRIND MIFs.
Figure 5The graphical display of GRIND variables with variables 279 of the DRY–O block, 576 of O–TIP and 638 of N1–TIP block for the selected compounds (a) 10 and (b) 9.
Figure 6HOMO and LUMO and the energy levels for the most active molecule 12.
Figure 7Molecular electrostatic potential map (in a.u.) of the most active molecule 12.